Status:
COMPLETED
Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA)
Lead Sponsor:
Omar Mamdouh Shaaban
Conditions:
Uterine Hemorrhage
Eligibility:
FEMALE
20-50 years
Phase:
PHASE3
Brief Summary
This study aims to test the effect of Doxycycline in treatment of uterine bleeding during the use of injectable contraception that contains one hormone "progesterone only".
Eligibility Criteria
Inclusion
- Women under DMPA contraception for at least one month.
- Accept to participate in the trial after receiving adequate information about the trial including information that she is a part of randomization comprising the possibility of receiving new treatment for bleeding or inactive ingredients.
- Women's ability to keep an accurate menstrual diary for the study.
Exclusion
- Lactating women for the fear of the effect of tetracycline on the breast-fed infant.
- Patients with already diagnosed local gynecological abnormality.
- Women receiving treatment for bleeding within the last one month.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT01254799
Start Date
January 1 2008
End Date
January 1 2011
Last Update
November 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Asyut, Asyut Governorate, Egypt